TXNIP and type 1 diabetes mellitus: TIX100 has just received clearance from the United States Food and Drug Administration (FDA) to start clinical trials and this Perspective therefore focuses on the identification, rationale, development, distinct properties and future implications of this novel class of TXNIP-inhibiting T1D drugs.